[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:epidermolysis-bullosa":3},{"name":4,"total":5,"trials":6,"biomarkers":22,"states":23},"Epidermolysis Bullosa",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05649098","Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders",[11],"Early Phase 1","RECRUITING","2026-08-03T03:36:30.249914Z","2026-05-05T02:43:28.484842Z",{"nct_id":16,"title":17,"phases":18,"status":19,"updated_at":20,"content_modified":21},"NCT07050810","Thera-Clean® Microbubbles System in Patients With Skin Diseases",[11],"ENROLLING_BY_INVITATION","2026-08-03T03:16:32.738962Z","2026-06-16T05:54:07.850307Z",[],[]]